Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Pathology Oncology Research : POR
|
January 15, 1999
Haptoglobin-related protein as a serum marker in malignant lymphoma
R Epelbaum, C Shalitin, R Segal, et al.
Cancer
|
September 15, 1990
Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables
R Epelbaum, D Faraggi, Y Ben-Arie, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
March 6, 2003
Minimal and best linear combination of oxidative stress and antioxidant biomarkers to discriminate cardiovascular disease
E F Schisterman, D Faraggi, R Browne, et al.
Harefuah
|
April 17, 2001
[The chemotherapeutic treatment of advanced Hodgkin's disease]
R Epelbaum, N Haim, M Ben-Shahar, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
February 1, 1992
Stage I-II low grade non-Hodgkin's lymphoma: prognostic factors and treatment results
R Epelbaum, A Kuten, N M Coachman, et al.
Statistics in Medicine
|
March 15, 1994
Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of action
A D Koutsoukos, L V Rubinstein, D Faraggi, et al.
QJM : Monthly Journal of the Association of Physicians
|
August 19, 2007
Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women
T Zornitzki, O Ayzenberg, G Gandelman, et al.
Cancer
|
October 15, 1991
Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group B
M W Oster, R L Schilsky, D Faraggi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2000
Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network
L M McShane, R Aamodt, C Cordon-Cardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 1998
Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network
P Lianes, E Charytonowicz, C Cordon-Cardo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Pathology Oncology Research : POR
|
January 15, 1999
Haptoglobin-related protein as a serum marker in malignant lymphoma
R Epelbaum, C Shalitin, R Segal, et al.
Cancer
|
September 15, 1990
Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables
R Epelbaum, D Faraggi, Y Ben-Arie, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
March 6, 2003
Minimal and best linear combination of oxidative stress and antioxidant biomarkers to discriminate cardiovascular disease
E F Schisterman, D Faraggi, R Browne, et al.
Harefuah
|
April 17, 2001
[The chemotherapeutic treatment of advanced Hodgkin's disease]
R Epelbaum, N Haim, M Ben-Shahar, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
February 1, 1992
Stage I-II low grade non-Hodgkin's lymphoma: prognostic factors and treatment results
R Epelbaum, A Kuten, N M Coachman, et al.
Statistics in Medicine
|
March 15, 1994
Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of action
A D Koutsoukos, L V Rubinstein, D Faraggi, et al.
QJM : Monthly Journal of the Association of Physicians
|
August 19, 2007
Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women
T Zornitzki, O Ayzenberg, G Gandelman, et al.
Cancer
|
October 15, 1991
Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group B
M W Oster, R L Schilsky, D Faraggi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2000
Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network
L M McShane, R Aamodt, C Cordon-Cardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 1998
Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network
P Lianes, E Charytonowicz, C Cordon-Cardo, et al.
Page
of 5